CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS

by A. V. Bogolyubova, G. A. Efimov, M. S. Drutskaya, S. A. Nedospasov
Published 2015-10-01

Prospects for Using the ELISPOT Technological Platform as Part of Anti-Epidemic Measures Against the New Coronavirus Infection COVID-19

by D. A. Poteryaev, R. A. Khamitov, G. A. Efimov, A. M. Shuster
Published 2020-09-01

IMMUNOBIOLOGY OF ACUTE GRAFT-VERSUS-HOST DISEASE

by G. A. Efimov, A. S. Vdovin, A. A. Grigoryev, S. Yu. Filkin, N. A. Bykova, V. G. Savchenko
Published 2016-01-01

CLINICALLY RELEVANT MINOR HISTOCOMPATIBILITY ANTIGENS FOR RUSSIAN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION

by D. S. Romaniuk, A. A. Khmelevskaya, A. M. Postovskaya, D. B. Malko, E. P. Kuzminova, E. G. Khamaganova, G. A. Efimov
Published 2019-12-01

Comparative analysis of minor histocompatibility antigens genotyping methods

by A. S. Vdovin, A. M. Postovskaya, N. A. Bykova, D. S. Romaniuk, A. K. Alieva, P. R. Yefimova, S. A. Sheetikov, H. L. Julhakyan, G. A. Efimov
Published 2016-08-01

Effect of <i>CTLA4</i> gene polymorphism on relapse probability among patients with acute leukemias after allogenic hematopoietic stem cells transplantation

by D. S. Romaniuk, A. A. Khmelevskaya, M. Yu. Drokov, N. N. Popova, V. A. Vasilieva, L. A. Kuzmina, G. A. Efimov, E. N. Parovichnikova, V. G. Savchenko
Published 2019-04-01